Commentary on "Complement C3 vs C5 inhibition in severe COVID-19 Early clinical findings reveal differential biological efficacy" by D.C. Mastellos et al

von de Miranda Santos, Isabel Kinney Ferreira
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2021)